M. B. Davies

595 total citations
12 papers, 476 citations indexed

About

M. B. Davies is a scholar working on Pathology and Forensic Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, M. B. Davies has authored 12 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in M. B. Davies's work include Multiple Sclerosis Research Studies (4 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Retinal and Optic Conditions (1 paper). M. B. Davies is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Retinal and Optic Conditions (1 paper). M. B. Davies collaborates with scholars based in United Kingdom, Netherlands and Japan. M. B. Davies's co-authors include Anthony A. Fryer, Clive Hawkins, M. Boggild, Richard C. Strange, Peter W. Jones, Carolyn Young, S. J. M. Weatherby, R. C. Strange, Philip N. Hawkins and Carl E Clarke and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and European Heart Journal.

In The Last Decade

M. B. Davies

10 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. B. Davies United Kingdom	9	231	138	104	90	89	12	476
Hai Yu China	11	199 0.9×	151 1.1×	84 0.8×	75 0.8×	54 0.6×	23	459
Simona Toscano Italy	11	233 1.0×	148 1.1×	45 0.4×	60 0.7×	61 0.7×	24	422
Naeem Mahfooz United States	7	150 0.6×	45 0.3×	72 0.7×	44 0.5×	81 0.9×	11	302
Takafumi Hosokawa Japan	11	132 0.6×	202 1.5×	52 0.5×	30 0.3×	72 0.8×	32	388
Hongshan Ma China	9	149 0.6×	145 1.1×	62 0.6×	61 0.7×	59 0.7×	13	317
Huijing Ye China	13	200 0.9×	120 0.9×	106 1.0×	45 0.5×	34 0.4×	54	469
Vibhavari Naik India	10	645 2.8×	159 1.2×	80 0.8×	31 0.3×	19 0.2×	28	823
Tetsuhiro Higashida Japan	10	38 0.2×	168 1.2×	208 2.0×	26 0.3×	38 0.4×	33	588
Nicolas Dubuisson Belgium	11	147 0.6×	63 0.5×	100 1.0×	66 0.7×	22 0.2×	23	364
Klaus Kallenbach Denmark	9	60 0.3×	39 0.3×	74 0.7×	17 0.2×	19 0.2×	19	368

Countries citing papers authored by M. B. Davies

Since Specialization

Citations

This map shows the geographic impact of M. B. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. B. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. B. Davies more than expected).

Fields of papers citing papers by M. B. Davies

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. B. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. B. Davies. The network helps show where M. B. Davies may publish in the future.

Co-authorship network of co-authors of M. B. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of M. B. Davies. A scholar is included among the top collaborators of M. B. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. B. Davies. M. B. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Gelderblom, Hans, Emanuela Palmerini, Jean‐Yves Blay, et al.. (2025). A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of emactuzumab in patients with tenosynovial giant cell tumor (TANGENT).. Journal of Clinical Oncology. 43(16_suppl).

D’Haens, Geert, Silvio Danese, M. B. Davies, Mamoru Watanabe, & Toshifumi Hibi∥. (2019). DOP48 Amiselimod, a selective S1P receptor modulator in Crohn’s disease patients: a proof-of-concept study. Journal of Crohn s and Colitis. 13(Supplement_1). S055–S056. 14 indexed citations

Davies, M. B., et al.. (2013). Spinal injury. BMJ. 346(jun07 3). f3374–f3374.

Howman, Andrew, Keith Wheatley, Michael Burdon, et al.. (2010). A randomised controlled trial of treatment for idiopathic intracranial hypertension. Journal of Neurology. 258(5). 874–881. 106 indexed citations

Bär, Frits W., Dan Tzivoni, Maurits T. Dirksen, et al.. (2006). Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-Elevation Myocardial Infarction: the randomized multicentre CASTEMI study. European Heart Journal. 27(21). 2516–2523. 58 indexed citations

Davies, M. B., V L Stevenson, Siobhan M Leary, et al.. (2002). Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. Journal of Neuroimmunology. 129(1-2). 197–204. 48 indexed citations

Weatherby, S. J. M., Wendy Thomson, L Pepper, et al.. (2001). HLA-DRB1 and disease outcome in multiple sclerosis. Journal of Neurology. 248(4). 304–310. 53 indexed citations

Weatherby, S. J. M., M. B. Davies, D Carthy, et al.. (2000). Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis. Multiple Sclerosis Journal. 6(1). 32–36. 50 indexed citations

Weatherby, S. J. M., et al.. (2000). A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis. Journal of Neurology. 247(6). 467–470. 35 indexed citations

10.

Davies, M. B., M. Boggild, Julie Alldersea, et al.. (2000). Glutathione S-transferase polymorphisms in MS. Neurology. 54(3). 552–552. 76 indexed citations

11.

Davies, M. B., et al.. (2000). A multiple-sclerosis-like syndrome associated with glue-sniffing. Journal of the Royal Society of Medicine. 93(6). 313–314. 4 indexed citations

12.

Davies, M. B., et al.. (1998). MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology. 40(12). 765–770. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact